Marek Grygier

Marek Grygier

Interventional cardiologist / Cardiologist
Poznan University of Medical Sciences - Poznan, Poland

Latest contributions

LAAC: current and future indications

03 Jun 2025

Watch the replay of this webinar and learn about the evidence (current guidelines and indications) for LAAC in 2025, and so much more!

TMVIV - TMVIR and its challenges

23 May 2025 – From EuroPCR 2025

Explore the challenges and innovations in transcatheter mitral valve-in-valve and valve-in-ring procedures. This session presents alternative access routes, management of paraannular compromise, and complex cases involving ECMO support and unexpected outcomes, offering valuable insights into advanced mitral interventions.

TMVIV - TMVIR and its challenges

Novelty in ACS diagnosis and treatment

22 May 2025 – From EuroPCR 2025

Discover novel diagnostic and therapeutic advances in acute coronary syndrome (ACS) management. This session covers innovative topics such as paclitaxel-coated balloon angioplasty safety in STEMI, the prognostic role of carbon monoxide, AI-based ECG prediction of infarct-related arteries, microcirculatory resistance indices in MINOCA, and real-world optical coherence...

Novelty in ACS diagnosis and treatment

Myval Octapro THV - Optimise patient outcomes with novel design, data and daily clinical practice

21 May 2025 – From EuroPCR 2025

This session presents the latest updates on the novel Myval Octapro transcatheter heart valve (THV), based on one year of real-world clinical experience. Experts share practical tips and clinical cases that highlight how this innovative device can improve TAVI patient outcomes. The session also addresses imaging and...

Myval Octapro THV - Optimise patient outcomes with novel design, data and daily clinical practice

Clinical impact of TAVI frame under-expansion and optimisation strategies

07 Mar 2025

Watch this replay with C. Cook, M. Grygier, A. Khokhar and W-K. Kim to learn about the clinical importance of TAVI frame under-expansion, and so much more!

TAVI: procedural complications - Part 2

16 May 2024 – From EuroPCR 2024

This session focuses on the management of procedural complications during transcatheter aortic valve implantation (TAVI). It presents a series of challenging cases, including valve-in-valve TAVI with complications, acute cardiogenic shock during valve-in-valve TAVI, and various other complications such as left ventricular perforation, fistula formation, and lost...

TAVI: procedural complications -  Part 2

Aortic valve-in-valve or TAV-in-TAV challenges

15 May 2024 – From EuroPCR 2024

This session comprises selected EuroPCR 2024 Clinical Case submissions focused on the challenges of aortic valve-in-valve or TAV-in-TAV procedures. The session will feature various complex cases, including when even two surgeries are not enough, resilient rhythms in geriatric resurgence, valve-in-valve TAVI for degenerated small surgical bioprosthetic...

Aortic valve-in-valve or TAV-in-TAV challenges

Management of patient with complex left main stenosis - LIVE case

14 May 2024 – From EuroPCR 2024

A 52-year-old male, with a history of STEMI treated by PPCI on RCA one month ago, presents with angina CCS 2 and severe, calcified stenosis in the LAD, CX, and distal left main. The treatment involved implanting 2 stents in the LAD after Rota preparation, followed...

Management of patient with complex left main stenosis - LIVE case

Mitral Late-Breaking Trials: CLASP IID, AltaValve transseptal programme, MitraSwiss in men and women, MiCLASP...

19 Nov 2023 – From PCR London Valves 2023

Discover the mitral late-breaking trials which were presented during PCR London Valves 2023: 

  • One-year outcomes of transcatheter mitral repair from the CLASP IID Registry
  • AltaValve transseptal programme update
  • Mitral TEER in men and women from MitraSwiss registry: is equality achieved?
  • Combined impact of mitral valve gradients and mitral regurgitation reduction...
Mitral Late-Breaking Trials - PCR London Valves 2023

TAVI in heavily calcified aortic disease - How to choose the proper treatment strategy?

18 May 2023 – From EuroPCR 2023

Consult this session if you want to outline how the heart team should individualise treatment for patients with complex calcified aortic stenosis, to review steps for TAVI in complex calcified aortic stenosis, and to learn about device selection and implantation techniques in calcified anatomies.

TAVI in heavily calcified aortic disease

Maintaining selective coronary access after TAVI and re-do TAVI procedures

28 Nov 2022 – From PCR London Valves 2022

Watch this session if you want to understand the various challenges when trying to get coronary access after TAVI, learn different techniques and discuss the options for coronary access after re-do TAVI.

Innovative coronary approches for your daily practice

20 May 2022 – From EuroPCR 2022

This EuroPCR 2022 session presents innovative types of coronary approches used in different Clinical Case submissions: severe calcific tortuous LAD disease, the calcium challenge or IVUS-guided CTO PCI with minimum contrast...

Innovative coronary approches for your daily practice

Looking at the heart and the brain - What is the role of LAA closure?

18 May 2022 – From EuroPCR 2022

Based on a pre-registered case study of a 68-year-old male patient, DG, who presented with atrial fibrillation, intracranial bleeding on warfarin, and compartment syndrome secondary to bleeding from warfarin, this EuroPCR 2022 session will allow you to discuss the challenges of treating AF patients with previous intracranial...

Looking at the heart and the brain - What is the role of LAA closure?

TAVI in a patient with asymptomatic severe aortic stenosis - Session with LIVE case

17 May 2022 – From EuroPCR 2022

Watch this LIVE demonstration from London, United Kingdom to find out how this asymptomatic, 70-year-old, overweight, previously CABG (205) male patient with permanent atrial fibrillation and unlimited exercise tolerance was treated. 

TAVI in a degenerated surgical valve - Session with LIVE demonstration

20 May 2021 – From EuroPCR 2021

Watch this session if you want to learn a step-by-step approach to valve in valve TAVI and to understand how to optimise haemodynamic outcomes of valve-in-valve TAVI.

This session was originally presented during EuroPCR 2021.

TAVI in a degenerated surgical valve

TAVI in a transcatheter aortic valve - Session with LIVE demonstration

20 May 2021 – From EuroPCR 2021

Watch this session if you want to learn a step-by-step approach to valve in valve TAVI and to understand how to optimise haemodynamic outcomes of valve-in-valve TAVI.

This session was originally presented during EuroPCR 2021.

TAVI in a transcatheter aortic valve

Culotte technique for bifurcation PCI - Session with LIVE demonstration

19 May 2021 – From EuroPCR 2021

Watch this session if you want to discuss which anatomy is suitable for the culotte stenting technique, to learn the steps of culotte stenting, and to review the pitfalls of culotte stenting.

This session was originally presented during EuroPCR 2021.

Culotte technique for bifurcation PCI

Managing acute coronary perforation: a simulation-based team approach

19 May 2021 – From EuroPCR 2021

Watch this session if you want to apprehend how to deal with unexpected occurances, to appreciate the importance of pre/de-briefing and immersive team simulation rehearsal, and to review the lifesaving actions in case of coronary perforation.

This session was originally presented during EuroPCR 2021.

Managing acute coronary perforation: a simulation-based team approach

Multivessel disease revascularisation: balancing the risk

19 May 2021 – From EuroPCR 2021

Watch this session presented by Jean Fajadet, Thomas Cuisset, Bruno Farah, Marek Grygier, Maciej Lesiak and Sylwia Iwanczyk in order to understand the selection of PCI for multivessel disease patients, to demonstrate the best treatment strategy for patients presenting with multivessel disease, and to discuss DAPT strategy in multivessel...

Multivessel disease revascularisation: balancing the risk